Singapore markets closed

Straits Times Index
3,287.75
-5.38(-0.16%)
S&P 500
5,003.95
-67.68(-1.33%)
Dow
37,805.53
-655.39(-1.70%)
Nasdaq
15,445.02
-267.73(-1.70%)
Bitcoin USD
63,395.68
-1,670.71(-2.57%)
CMC Crypto 200
1,372.59
-9.98(-0.72%)

Merrimack Pharmaceuticals, Inc. (MACK)

NasdaqGM - NasdaqGM Real-time price. Currency in USD

Add to watchlist

14.71

0.00

(0.00%)

As of 11:04AM EDT. Market open.

Trade prices are not sourced from all markets

All

Business Wire
Merrimack Receives $225 Million Milestone Payment from Ipsen
CAMBRIDGE, Mass., March 27, 2024--Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK) ("Merrimack" or the "Company") today announced that it has received a $225 million payment which was due from Ipsen, S.A. as a result of its receipt of approval from the U.S. Food and Drug Administration, or FDA, to market ONIVYDE as a first-line treatment of metastatic adenocarcinoma on the pancreas.
Business Wire
Merrimack Reports Full Year 2023 Financial Results
CAMBRIDGE, Mass., March 07, 2024--Merrimack Reports Full Year 2023 Financial Results
Simply Wall St.
Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) is definitely on the radar of hedge funds investors who own 35% of the company
Key Insights Significantly high institutional ownership implies Merrimack Pharmaceuticals' stock price is sensitive to...